Evidence map›Paper›PMID 32205883›Full record

ArticleNature immunology2020

Reverse TCR repertoire evolution toward dominant low-affinity clones during chronic CMV infection.

Kilian Schober, Florian Voit, Simon Grassmann, Thomas R Müller, Joel Eggert, Sebastian Jarosch, Bianca Weißbrich, Patrick Hoffmann, Lisa Borkner, Enzo Nio and 13 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 114 citations in OpenAlex.

  1. Clonal selection of somatic mutations shapes NK cell memory.bioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Article
  4. CD8Science China. Life sciences · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. A pain from the nose to the head: neurological commitment during long COVID.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 3 countries.

Kilian Schober *Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany. kilian.schober@tum.de.ORCID http://orcid.org/0000-0001-9323-9472
Florian Voit *Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany.ORCID http://orcid.org/0000-0002-6957-6628
Simon GrassmannInstitute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany.
Thomas R MüllerInstitute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany.ORCID http://orcid.org/0000-0001-5331-5522
Joel EggertInstitute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany.
Sebastian JaroschInstitute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany.
Bianca WeißbrichInstitute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany.
Patrick HoffmannInstitute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany.
Lisa BorknerDepartment of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Enzo NioENPICOM B.V., 's-Hertogenbosch, the Netherlands.
Lorenzo FanchiENPICOM B.V., 's-Hertogenbosch, the Netherlands.
Christopher R ClouserJuno Therapeutics/Celgene, Seattle, WA, USA.
Aditya RadhakrishnanJuno Therapeutics/Celgene, Seattle, WA, USA.
Lorenz MihatschInstitute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany.
Philipp LückemeierInstitute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany.
Justin LeubeInstitute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany.
Georg DössingerInstitute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany.
Ludger KleinInstitute for Immunology, Ludwig-Maximilians-Universität, Munich, Germany.
Michael NeuenhahnInstitute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany.
Jennifer D OduroDepartment of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Luka Cicin-SainGerman Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany.
Veit R BuchholzInstitute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany.ORCID http://orcid.org/0000-0003-0441-3913
Dirk H BuschInstitute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany. dirk.busch@tum.de.ORCID http://orcid.org/0000-0001-8713-093X
Institute of Medical Microbiology and Hygiene · DEENPICOM (Netherlands) · NLHelmholtz Centre for Infection Research · DEGerman Center for Infection Research · DELudwig-Maximilians-Universität München · DEMedizinische Hochschule Hannover · DETumaini University · TZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adaptive evolution is a key feature of T cell immunity. During acute immune responses, T cells harboring high-affinity T cell antigen receptors (TCRs) are preferentially expanded, but whether affinity maturation by clonal selection continues through the course of chronic infections remains unresolved. Here we investigated the evolution of the TCR repertoire and its affinity during the course of infection with cytomegalovirus, which elicits large T cell populations in humans and mice. Using single-cell and bulk TCR sequencing and structural affinity analyses of cytomegalovirus-specific T cells, and through the generation and in vivo monitoring of defined TCR repertoires, we found that the immunodominance of high-affinity T cell clones declined during the chronic infection phase, likely due to cellular senescence. These data showed that under conditions of chronic antigen exposure, low-affinity TCRs preferentially expanded within the TCR repertoire, with implications for immunotherapeutic strategies.

Indexed as

AnimalsCellular SenescenceCytomegalovirusCytomegalovirus InfectionsFemaleHumansMiceMice, Inbred C57BLReceptors, Antigen, T-CellT-LymphocytesReceptors, Antigen, T-Cell

Identifiers

PMID32205883
OpenAlexW3010735835

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.